Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

1.

Advances in the use of botulinum neurotoxins in facial esthetics.

Flynn TC.

J Cosmet Dermatol. 2012 Mar;11(1):42-50. doi: 10.1111/j.1473-2165.2011.00593.x. Review.

PMID:
22360334
[PubMed - indexed for MEDLINE]
2.

IncobotulinumtoxinA in esthetics.

Kerscher M, Yutskovskaya Y, Flynn TC.

J Drugs Dermatol. 2013 Jun 1;12(6):e111-20. Review.

PMID:
23839200
[PubMed - indexed for MEDLINE]
3.

Botulinum toxin: examining duration of effect in facial aesthetic applications.

Flynn TC.

Am J Clin Dermatol. 2010;11(3):183-99. doi: 10.2165/11530110-000000000-00000. Review.

PMID:
20369902
[PubMed - indexed for MEDLINE]
4.

International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.

Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaén P, Monheit GD, Rzany B, Viel M.

J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1278-84. doi: 10.1111/j.1468-3083.2010.03631.x.

PMID:
20337830
[PubMed - indexed for MEDLINE]
5.

Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.

Jandhyala R.

J Plast Reconstr Aesthet Surg. 2012 Jun;65(6):720-31. doi: 10.1016/j.bjps.2011.12.001. Epub 2012 Jan 4.

PMID:
22225675
[PubMed - indexed for MEDLINE]
6.

Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.

Frevert J.

Drugs R D. 2010;10(2):67-73. doi: 10.2165/11584780-000000000-00000.

PMID:
20698714
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Botulinum neurotoxin A: a review.

Berry MG, Stanek JJ.

J Plast Reconstr Aesthet Surg. 2012 Oct;65(10):1283-91. doi: 10.1016/j.bjps.2012.04.016. Epub 2012 Apr 30. Review.

PMID:
22552262
[PubMed - indexed for MEDLINE]
8.

Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidence.

Jandhyala R.

J Drugs Dermatol. 2012 Jun;11(6):731-6.

PMID:
22648220
[PubMed - indexed for MEDLINE]
9.

International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.

Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Jaén P, Monheit GD, Rzany B, Viel M.

J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1285-95. doi: 10.1111/j.1468-3083.2010.03728.x.

PMID:
20569284
[PubMed - indexed for MEDLINE]
10.

Botulinum toxin type A for aging face and aesthetic uses.

Hexsel C, Hexsel D, Porto MD, Schilling J, Siega C.

Dermatol Ther. 2011 Jan-Feb;24(1):54-61. doi: 10.1111/j.1529-8019.2010.01378.x.

PMID:
21276158
[PubMed - indexed for MEDLINE]
11.

Botulinum toxin products overview.

Carruthers A, Carruthers J.

Skin Therapy Lett. 2008 Jul-Aug;13(6):1-4.

PMID:
18806905
[PubMed - indexed for MEDLINE]
Free Article
12.

Comparison of the spread of three botulinum toxin type A preparations.

Kerscher M, Roll S, Becker A, Wigger-Alberti W.

Arch Dermatol Res. 2012 Mar;304(2):155-61. doi: 10.1007/s00403-011-1179-z. Epub 2011 Oct 15.

PMID:
22002325
[PubMed - indexed for MEDLINE]
13.

Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins.

Dressler D.

Eur J Neurol. 2012 Mar;19(3):385-9. doi: 10.1111/j.1468-1331.2011.03559.x. Epub 2011 Oct 28. Review.

PMID:
22035051
[PubMed - indexed for MEDLINE]
14.

Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.

Jost WH, Blümel J, Grafe S.

Drugs. 2007;67(5):669-83. Review.

PMID:
17385940
[PubMed - indexed for MEDLINE]
15.

Comparisons among botulinum toxins: an evidence-based review.

Klein AW, Carruthers A, Fagien S, Lowe NJ.

Plast Reconstr Surg. 2008 Jun;121(6):413e-422e. doi: 10.1097/PRS.0b013e318170813c. Review.

PMID:
18520868
[PubMed - indexed for MEDLINE]
16.

Correcting age-related changes in the face by use of injectable fillers and neurotoxins.

Rubin MG, Cox SE, Kaminer MS, Solish N.

Semin Cutan Med Surg. 2014 Jun;33(4 Suppl):S81-4. doi: 10.12788/j.sder.0101.

PMID:
25268602
[PubMed - indexed for MEDLINE]
17.

Botulinum toxin (Botox) to enhance facial macroesthetics: a literature review.

Dastoor SF, Misch CE, Wang HL.

J Oral Implantol. 2007;33(3):164-71. Review.

PMID:
17674683
[PubMed - indexed for MEDLINE]
18.

Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.

Fagien S.

Plast Reconstr Surg. 2003 Oct;112(5 Suppl):6S-18S; discussion 19S-20S.

PMID:
14504481
[PubMed - indexed for MEDLINE]
19.

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins.

Jimenez-Shahed J.

Neuropsychiatr Dis Treat. 2012;8:13-25. doi: 10.2147/NDT.S16085. Epub 2011 Dec 23.

PMID:
22275842
[PubMed]
Free PMC Article
20.

The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.

Wortzman MS, Pickett A.

Aesthet Surg J. 2009 Nov;29(6 Suppl):S34-42. doi: 10.1016/j.asj.2009.09.014. Review.

PMID:
19945003
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk